Please login to the form below
Olmesartan franchise
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Olmesartan franchise was produced by Daiichi Sankyo.
Lilly announces two new senior leadership hires
Her previous roles including five years at Novartis, where she held both UK and regional positions within its neuroscience franchise.
Sobi to acquire CTI BioPharma for approximately $1.7bn
Guido Oelkers, Sobi’s president and chief executive officer, said: “CTI represents a perfect fit for Sobi’s haematology franchise today, adding a powerful and highly differentiated new product that will
Ipsen to acquire rare disease specialist Albireo in deal worth over $950m
Commenting on the acquisition, Ipsen’s chief executive officer, David Loew, said: “Our rare disease franchise is strengthened with Bylvay, which, in addition to being the first-approved treatment in PFIC,
Sponsors
Realise the value of their innovations for patients through brand and franchise positioning, commercial strategy and operational preparedness.
LaunchPad - Designed with You, for You
LaunchPad is so successful that three other brands (across 2 franchises) have built launchpads, with the concept winning a BMS internal innovation award and Communiqué Award for Excellence in Medical Affairs –
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Top 10 benefits of virtual advisory boards: Save Time and Resources
- NIHR launches new framework to highlight health progress outcomes
- Johns Hopkins and National Cancer Unit develop new genetic risk-scoring method for major diseases
- UKHSA secures UK-based vaccine deal for future influenza pandemics
- Novo Nordisk and Valo Health agree deal worth up to $3.3bn to develop cardiovascular treatments
- Landscape review reveals £1.1bn of UK funding for rare diseases
No results were found
PMHub
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
